InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
20
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Dunlop A. Sinclair, Director. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 37 disclosures have been logged. Breakdown: 0 buy · 20 sells. Total volume traded: €14m. History available since 18 May 2021. The latest transaction was filed on 1 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Dunlop A. Sinclair
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations37 total
161,567 sharesCommon StockSEC:0001193125-26-224633:0
7,961 shares0Common StockSEC:0001492422-26-000013:0
4,787 shares0Common StockSEC:0001193125-25-240563:0
31,092 shares@ US$22.585.3% of flowCommon StockSEC:0001193125-25-228277:0
31,092 shares@ US$22.955.7% of flowCommon StockSEC:0001193125-25-209537:0
6,267 shares0Common StockSEC:0001127602-25-000419:0
4,600 shares@ US$13.190.5% of flowCommon StockSEC:0001127602-24-024373:0
29,476 shares@ US$36.099.5% of flowCommon StockSEC:0000950170-24-107411:0
7,524 shares@ US$36.792.5% of flowCommon StockSEC:0000950170-24-107411:1
900 shares@ US$13.190.1% of flowCommon StockSEC:0001127602-24-019521:0
35,305 shares@ US$39.2212.8% of flowCommon StockSEC:0000950170-24-076423:0
1,500 shares@ US$13.190.2% of flowCommon StockSEC:0001127602-24-012884:0
18,681 shares@ US$57.1799.7% of flowCommon StockSEC:0000950170-24-034277:0
3,341 shares0Common StockSEC:0001127602-24-000110:0
6,274 shares@ US$13.190.8% of flowCommon StockSEC:0001127602-23-029691:0
24,000 shares@ US$61.13513.3% of flowCommon StockSEC:0000950170-23-068183:0
24,000 shares@ US$49.0011.0% of flowCommon StockSEC:0000899243-23-020450:0
8,894 shares@ US$49.9914.1% of flowCommon StockSEC:0001127602-23-028142:0
500 shares@ US$74.050.3% of flowCommon StockSEC:0001127602-23-012600:0
500 shares@ US$65.330.3% of flowCommon StockSEC:0001127602-23-008357:0
500 shares@ US$52.610.2% of flowCommon StockSEC:0001127602-23-003104:0
500 shares@ US$50.700.2% of flowCommon StockSEC:0001127602-23-001000:0
3,867 shares0Common StockSEC:0000899243-23-000673:0
500 shares@ US$49.930.2% of flowCommon StockSEC:0000899243-22-037440:0
500 shares@ US$60.830.3% of flowCommon StockSEC:0000899243-22-034916:0
25 of 37 declarations
About Dunlop A. Sinclair
Dunlop A. Sinclair is a Director at Apellis Pharmaceuticals, Inc. He has 37 filings in total, and across the 37 sampled filings between 2021-05-20 and 2026-05-14, the recorded transactions are sales totaling EUR 14015494, with no purchases reported.
